Breast Cancer

An article published in the October issue of Mayo Clinic Proceedings offers recommendations regarding supplemental screening for women with dense breast tissue.

Only a small percentage of women are considered to be at high risk for developing breast cancer due to family history, genetic mutation, or tissue-based findings that elevate their odds.

Sen. Amy Klobuchar held a press conference at Mayo Clinic in Rochester, Minnesota, on Oct. 14 to promote the use of preventive health services and emphasize the importance of breast cancer screening.

The findings of the CARRIERS Consortium study, which were published Wednesday, Jan. 20, 2021 in The New England Journal of Medicine, may allow health care[...]

Research from Mayo Clinic investigators presented at the 2019 San Antonio Breast Cancer Symposium suggests that some women with an elevated risk of developing breast[...]

Donald W. Northfelt, M.D., an oncologist and breast cancer researcher at Mayo Clinic in Phoenix, Arizona, talks about his research, his mentors and promoting equity in clinical trials.

Studies show that the risk of breast cancer can be reduced by half through the use of a five-year course of tamoxifen or raloxifene and[...]

Research led by Mayo Clinic oncologists Roberto A. Leon Ferre, M.D., and Charles L. Loprinzi, M.D., has found that the drug oxybutynin helps reduce the[...]

A less-invasive nipple-sparing mastectomy that leaves the surface of the breast intact has become a safe option for more patients, including those whose breast cancer[...]

Treating breast cancer has long involved addressing two problems: the elimination of cancer cells from the tumor and potential disease recurrence. The key may be[...]